Startups
Endologix LLC is a California-based, global medical device company dedicated to improving patients’ lives by providing innovative therapies for the interventional treatment of vascular disease.
We have a therapeutic portfolio designed to treat diseases which currently have clinically relevant unmet needs. Our existing products can treat a wide spectrum of vascular disease through abdominal aortic aneurysms to lower limb peripheral vascular disease. We obtain excellent clinical outcomes through meticulous attention to product design, manufacturing, and training, all backed by industry-leading clinical evidence.
With a robust pipeline of disruptive technology, our vision is to provide physicians with the best device for each patient; because when it comes to ensuring patient well-being, we are never satisfied with the status quo.
We have a therapeutic portfolio designed to treat diseases which currently have clinically relevant unmet needs. Our existing products can treat a wide spectrum of vascular disease through abdominal aortic aneurysms to lower limb peripheral vascular disease. We obtain excellent clinical outcomes through meticulous attention to product design, manufacturing, and training, all backed by industry-leading clinical evidence.
With a robust pipeline of disruptive technology, our vision is to provide physicians with the best device for each patient; because when it comes to ensuring patient well-being, we are never satisfied with the status quo.
Overview
Location
United States, California, Irvine
Employees
501-1000
Founded date
1992
Mentions in press and media 10
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 21, 2022 | UPDATE on Type III Endoleaks Associated with Endovascular Graft Systems – Letter to Health Care Providers | On October 28, 2019, the FDA issued a Safety Communication to provide an update on Type III Endoleaks Associated with Use of Endologix AFX Endovascular AAA Graft Systems. October 15, 2018 - The FDA has issued a Class I recall to notify pati... |
| Aug 14, 2019 | Endologix looks to raise $25m in stock offering | Endologix (NSDQ:ELGX) has registered a stock offering of up to $25 million, according to a regulatory filing. The Irvine, Calif.-based company has engaged Piper Jaffray to offer more than 22.2 million shares of common stock at $6.45 per sha... |
| Aug 9, 2019 | Endologix shares dip on Q2 loss of $27.1 million | Shares in Endologix (NSDQ:ELGX) slipped by 8% to $6.06 apiece in midday trading today following yesterday’s second-quarter results that beat The Street on earnings expectations and sales. The Irvine, Calif.-based company reported a net loss... |
| Aug 23, 2016 | Lombard Medical goes for Americexit and possible sale | Lombard Medical laid the blame for its Americexit on an FDA decision that would require it to perform a 50-patient IDE (investigational device exemption) trial for the U.S. approval of its next-generation IntelliFlex delivery system. “Unfor... |
| Dec 13, 2010 | Endologix closes Nellix takeover | Endologix Inc. (NSDQ:ELGX) closed its acquisition of Palo Alto, Calif.-based Nellix. The all-stock deal, which Endologix announced Oct. 27, expands its aortic disorder treatment devices. The Irvine, Calif.-based company said the merger is d... |
| Oct 28, 2010 | Endovascular stent maker Endologix to buy Nellix for $15M | “We believe Nellix is the most revolutionary [endovascular aortic repair] technology in the world and will help position Endologix as the innovation leader in aortic aneurysm treatment. Nellix has developed a new technology that will allow ... |
| Oct 28, 2010 | Endologix Buys Nellix, Gets $15M Investment | Irvine-based Endologix, a developer of minimally invasive treatments for aortic disorders, said this morning that it has agreed to acquire Nellix, a developer of medical devices for treating abdominal aortic aneurysms (AAAs). Endologix said... |
| Lombard Medical goes for Americexit and possible sale | Lombard Medical is pulling out of the U.S. after failing to gain traction the U.K.-based company announced Monday. Lombard Medical, which makes the Aorfix Endovascular Stent Graft to treat abdominal aortic aneurysms, has eliminated its enti... | |
| Endovascular stent maker Endologix to buy Nellix for $15M | Endologix Inc. (NSDQ:ELGX) signed a deal to acquire Nellix Inc. for $15 million in stock, the company said today. The Irvine, California-based developer of aortic disorder devices hopes the deal increases its share of the aortic repair mark... |
Reviews 0
FAQ about Endologix LLC
When was Endologix LLC founded?
Endologix LLC was founded in 1992.
What has the press written about Endologix LLC?
Parsers VC has collected 10 articles mentioning Endologix LLC, among them “UPDATE on Type III Endoleaks Associated with Endovascular Graft Systems – Letter to Health Care Providers” (Jun 21, 2022) and “Endologix looks to raise $25m in stock offering” (Aug 14, 2019).
Is Endologix LLC still active?
Yes, Endologix LLC is active; its latest activity on Parsers VC dates from Nov 12, 2025.